Results 1 - 18 from 18 for "labormed"
-
Electrica Furnizare Develops PV Panels For Labormed Pharma Factory In Bucharest
11.29.2022
Electricity supplier Electrica Furnizare, part of Electrica Group, concluded a partnership with Zentiva Romania for the installation of photovoltaic (PV) panels at the Labormed Pharma production and more
-
Zentiva Completes Acquisition of Alvogen's CEE Operations Including Romanian Labormed
04.07.2020
Zentiva Group, owned by Advent International, announced Tuesday it has completed the acquisition of Alvogen's Central and Eastern European (CEE) business. more
-
Zentiva Group Buys Alvogen’s Operations In CEE, Including Labormed Plant In Romania
10.25.2019
-
Labormed Wants Drugs Cheaper Than RON10 Off Reimbursed List Over Clawback Tax
02.10.2015
Generics producer Labormed, part of Alvogen, is reassessing its medicines portfolio until March to remove products cheaper than RON10 from the reimbursed medicines list, as its sales rose 2% in value more
-
Labormed Raises Share Capital By EUR55M, Alvogen Lux Holdings Becomes Shareholder
11.17.2014
Romanian generic drug producer Labormed Pharma will raise its share capital by EUR55 million by converting into shares part of a EUR85.28 million receivable it owes Alvogen Lux Holdings S.a.r.l., more
-
Labormed Posts 61% Higher Sales, 84% Lower Loss In 2013, 1st Year Under Alvogen’s Control
06.11.2014
Sales of Romanian generic drug producer Labormed Pharma surged nearly 61% to 141.8 million lei (EUR32 million) and its loss narrowed by 84% to RON18 million in 2013, the first year under the ownership more
-
Advent Sold Labormed For $33M, 20% Of Acquisition Price
03.13.2014
Investment fund Advent sold Romanian generic drug producer Labormed last year to U.S. pharmaceutical company Alvogen for $33 million (EUR24 million), less than 20% of the acquisition price paid back more
-
PlantExtrakt Reintroduces In Its Portfolio 12 Brands Sold To Labormed In 2009
11.22.2013
Cluj-based company Laboratoarele PlantExtrakt, which produces homeopathic medicines and herbal remedies, has reintroduced in its portfolio the 12 brands it had sold to Romanian drug producer Labormed more
-
Stephen Stead Returns To Pharmaceutical Market As Ranbaxy Regional Director
10.22.2013
British-born Stephen Stead, who in August 2012 stepped down as CEO of Labormed, has returned to the pharmaceutical industry in a regional position within Ranbaxy and is based in Romania. He is more
-
Alvogen Aims For 15% Growth In 2014
10.02.2013
Alvogen and Labormed Pharma, which the former bought last December, will post 265 million lei (EUR60 million) revenue in 2013, says Laurentiu Scheusan, Alvogen’s executive vice-president in Central more
-
Advent’s Portfolio In Romania Includes Only Two Companies After Two More Exits
08.29.2013
Investment fund Advent Internaţinal sold two of its Romanian businesses over the past year: medical drug producer Labormed in August 2012 and paint maker Deutek this month. more
-
New Owner Of Labormed Wants Less Reliance On Romanian Market
04.09.2013
The priority of the new owner of pharmaceutical producer Labormed, Alvogen, is to make the company less reliant on the Romanian market, says Laurentiu Scheusan, Alvogen’s executive vice president of more
-
U.S. Alvogen Acquires Generic Drug Maker Labormed
01.31.2013
U.S. pharmaceutical company Alvogen on Thursday said it acquired Romanian generic drug producer Labormed in December 2012 from private equity firm Advent International. more
-
Negotiations On Labormed’s Takeover By U.S. Alvogen Almost Finished
01.14.2013
Negotiations on the takeover of Romanian drug producer Labormed by U.S. pharmaceutical company Alvogen from investment fund Advent are almost finished and a decision on the matter will be presented in more
-
Investors In Talks To Take Over Labormed
12.13.2012
Several investors are interested in drugmaker Labormed, one of the few acquisition targets on the Romanian pharmaceutical market, as integration into an international giant could open up a new more
-
Stephen Stead On Labormed: After We Tripled Sales, We Defended The Company Against Market Challenges
08.21.2012
Stephen Stead, the British executive who abruptly stepped down as manager of pharmaceutical manufacturer Labormed two weeks ago, talked for the first time about the reasons behind his decision to more
-
Advent To Make Discreet Exit From Labormed
08.14.2012
International private equity firm Advent International is preparing a discreet exit from Labormed in a complex process, which will in a first stage involve handing over its stake to individuals, more
-
Stead, Labormed CEO: Market Is Extremely Volatile, Forecasts Change Monthly
10.17.2011
Stephen Stead, chief executive officer of pharmaceutical company Labormed, controlled by investment fund Advent International, says that things are extremely volatile on the drug market and although more